Anebulo Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,431 | -2,403 | -2,141 | -1,290 |
EBIT | -3,323 | -2,403 | -2,412 | -1,340 |
Net Income | -1,676 | -2,463 | -2,201 | -1,350 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,601 | -1,405 | -1,689 | -2,052 |
Cash | 13,279 | 14,998 | 1,404 | 3,094 |
Basic Shares | 27,415 | 27,415 | 25,933 | 25,822 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -8,050 | -11,783 | 5 | -30,241 |
EBIT | -8,308 | -11,783 | -6,825 | -33,854 |
Net Income | -8,202 | -11,732 | -6,826 | -30,253 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,090 | -9,683 | -5,437 | -4,871 |
Cash | 3,094 | 11,247 | 14,548 | 19,985 |
Basic Shares | 25,822 | 25,074 | 23,345 | 23,345 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.05 |
2025-03-31 | -$0.04 |
2024-12-31 | -$0.08 |
